Nematode neuromuscular system

The nematode neuromuscular system is a complex physiological network comprising the central and peripheral nervous systems and the body-wall muscles of parasitic worms (Martin, 1997). It is the primary target for most anthelmintic drugs, which aim to disrupt the parasite's ability to move, feed, or maintain its position within the host (Wolstenholme, 2012). Key molecular components targeted within this system include nicotinic acetylcholine receptors (nAChRs), glutamate-gated chloride channels (GluCls), and GABA receptors (Holden-Dye & Walker, 2014). Drugs like levamisole and pyrantel act as cholinergic agonists to induce spastic paralysis, while macrocyclic lactones like ivermectin cause flaccid paralysis by opening GluCls (Geary et al., 1999). Because many of these ion channels are either absent or significantly different in vertebrate hosts, they allow for effective treatment with minimal host toxicity (James et al., 2009). However, the widespread use of these drugs has led to significant resistance, necessitating the search for new targets within the neuromuscular framework, such as the SLO-1 potassium channels targeted by emodepside (Harder et al., 2005).

Other names

Nematode nervous systemNematode muscle-nerve complexNematode motor system

Anthelmintic drugs target this system by acting as agonists or modulators of ligand-gated ion channels (e.g., nAChR, GluCl, GABA receptors), leading to hyperpolarization or persistent depolarization of muscle cells, resulting in flaccid or spastic paralysis of the nematode (Holden-Dye & Walker, 2014).